Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MUPIROCIN vs MUROMONAB-CD3: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MUPIROCIN vs MUROMONAB-CD3: Safety Overview

Metric MUPIROCIN MUROMONAB-CD3
Total FAERS Reports 3,459 114
Deaths Reported 32 28
Death Rate 0.9% 24.6%
Hospitalizations 352 28
Average Patient Age 58.6 yrs 30.2 yrs
% Female Patients 79.7% 45.0%
FDA Approval Date Apr 27, 2020 N/A
Manufacturer Alembic Pharmaceuticals Limited N/A
Route TOPICAL N/A
Marketing Status Discontinued N/A